A double-blind comparison of fluspirilene and fluphenazine decanoate in 28 schizophrenic patients over six months showed equal improvement and the same incidence of side-effects in each group of patients. It would be expected from the literature that a better ratio of therapeutic to side-effects would appear with fluspirilene than with fluphenazine. The absence of such an effect in this study may be attributable to an initial lack of familiarity by the investigators with the use of fluspirilene, indicating an important potential variable in the comparison of a new drug with an established one.
SterkmansP., BrugmansJ., GeversF.Clinical evaluation of fluspirilene (R 6218). A long-acting injectable neuroleptic.Clin Trials J1969; 6: 19–25.
3.
KingstoneE.The use of fluphenazine enanthate in an outpatient clinic.Int J Clin Pharmacol1968; 1: 413–16.
4.
ChouinardG., BanT.A., LehmannH.E., AnanthJ.J.V.Fluspirilene in the treatment of chronic schizophrenic patients.Curr Ther Res1970; 12: 604–8.
5.
VilleneuveA., DogonK., LachanceR., ProulxC.A controlled study of fluspirilene in chronic schizophrenia.Curr Ther Res1970; 12: 819–27.
6.
KingstoneE., KolivakisT., EngelsmannF.Fluspirilene (R 6218). A study of its efficacy and safety in out-patients. In: VilleneuveA. ed. The diphenylbutylpiperidines.Quebec: Les Presses de l'Université Laval1972: 86–98.
7.
St. LaurentJ., CarieR., DominiqueD.Fluspirilene in the treatment of chronic out-patients.Curr Ther Res1972; 14(9): 599–608.
8.
De AlarconR., CarneyM.W.P.Severe depressive mood changes following slow-release intramuscular fluphenazine injections.Br Med J1969; 3: 564–7.
9.
SvestkaJ., NahunekK., HadlikJ., RodovaA.Clinical experience with fluspirilene in psychoses.Activitas Nervosa Superior1971; 13(3): 173–4.
10.
FrangosH., ZissisN.P., LeontopoulosI.,Double-blind therapeutic evaluation of fluspirilene compared with fluphenazine decanoate in chronic schizophrenics.Acta Psychiatr Scand1978; 57: 436–46.
11.
MagnusR.V.A comparative study of fluspirilene and fluphenazine decanoate in schizophrenic patients.J Pharmacother1979; 3: 109–13.
12.
MalmU., PerrisC., RappW., WedrenG.A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes.Acta Psychiatr Scand1974; 249: 94–116.
13.
ECDEU Assessment Manual for Psychopharmacology, revised 1976. ed. GuyW., U.S. Department of Health, Education and Welfare, Publication No. (ADM) 76–338.
ChouinardG., AnnableL., Ross-ChouinardA.A double-blind controlled study of fluphenazine decanoate and enanthate in the maintenance treatment of schizophrenic outpatients. In: AydF.J.Jr. ed. Depot fluphenazines: twelve years’ experience.Baltimore: Ayd Medical Communications1978: 111–23.
